Class IITerminatedD-0150-2017
Drug recall · November 30, 2016
LEVOXYL(R) recall
Why: Superpotent
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
LEVOXYL(R) (levothyroxine sodium tablets, USP), 200 mcg, 100 count bottles, Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620, NDC 60793-860-01
- Lots / codes
16H21, Exp. 08/2017
- Quantity
- 2,666 bottles
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide
- Initiated
- November 7, 2016 · Voluntary: Firm initiated
- Classified
- November 23, 2016
- Reported
- November 30, 2016
- Ended
- May 1, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Levoxyl
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.